Meissa Vaccines, Inc.

ACTIVE

加利福尼亚州旧金山县, California, United Stateswww.meissavaccines.comHolding11–50 employeesEstablished: 2014-01-01

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2014

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

80.0%

Phase 2

20.0%

Trial Status Distribution

Completed

60.0%

Unknown

40.0%

Clinical Trials

Trials sponsored by this organization (5)

Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seronegative Children 6-36 Months

Phase 1

Unknown

interventional

Jun 202163 participants

Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults

Phase 1

Unknown

interventional

Apr 2021130 participants

Human Challenge Study to Evaluate the Efficacy of MV-012-968 Vaccine

Phase 2

Completed

interventional

Dec 202060 participants

Study of the Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seropositive Children

Phase 1

Completed

interventional

Jun 202034 participants

Safety and Immune Response to an Investigational Vaccine Against Respiratory Syncytial Virus in Healthy Adults

Phase 1

Completed

interventional

Jan 202020 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations